Michael Hasselle, MD
Radiation Oncologist
Emory University School of Medicine
Medical School
Residency; University of Chicago
University of Tennessee
Internship
American Board of Radiology - Radiation Oncology
GA State Medical License Active through 2019
Stereotactic body radiotherapy for the treatment of oligometastatic renal cell carcinoma.
Ranck, M. C.,Golden, D. W.,Corbin, K. S.,Hasselle, M. D.,Liauw, S. L.,Stadler, W. M.,Hahn, O. M.,Weichselbaum, R. R.,Salama, J. K.; Am. J. Clin. Oncol.. 2012 Aug 08.
See more >>Outcomes for patients with cervical cancer treated with extended-field intensity-modulated radiation therapy and concurrent cisplatin.
Jensen, L. G.,Hasselle, M. D.,Rose, B. S.,Nath, S. K.,Hasan, Y.,Scanderbeg, D. J.,Yashar, C. M.,Mundt, A. J.,Mell, L. K.; Int J Gynecol Cancer. 2013 Jan.
See more >>The effect of treatment time in locally advanced cervical cancer in the era of concurrent chemoradiotherapy.
Song, S.,Rudra, S.,Hasselle, M. D.,Dorn, P. L.,Mell, L. K.,Mundt, A. J.,Yamada, S. D.,Lee, N. K.,Hasan, Y.; Cancer. 2013 Jan 15.
See more >>